Shin Nippon Biomedical Laboratories Ltd
TSE:2395
Shin Nippon Biomedical Laboratories Ltd
Cash from Operating Activities
Shin Nippon Biomedical Laboratories Ltd
Cash from Operating Activities Peer Comparison
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
S
|
Shin Nippon Biomedical Laboratories Ltd
TSE:2395
|
Cash from Operating Activities
¥1.9B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
N/A
|
CMIC Holdings Co Ltd
TSE:2309
|
Cash from Operating Activities
¥6.7B
|
CAGR 3-Years
0%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
3%
|
|
Medinet Co Ltd
TSE:2370
|
Cash from Operating Activities
-¥1.3B
|
CAGR 3-Years
-26%
|
CAGR 5-Years
13%
|
CAGR 10-Years
-9%
|
|
CellSource Co Ltd
TSE:4880
|
Cash from Operating Activities
¥846.7m
|
CAGR 3-Years
37%
|
CAGR 5-Years
32%
|
CAGR 10-Years
N/A
|
|
Linical Co Ltd
TSE:2183
|
Cash from Operating Activities
¥1.8B
|
CAGR 3-Years
143%
|
CAGR 5-Years
29%
|
CAGR 10-Years
25%
|
|
WDB coco Co Ltd
TSE:7079
|
Cash from Operating Activities
¥517.5m
|
CAGR 3-Years
12%
|
CAGR 5-Years
27%
|
CAGR 10-Years
N/A
|
See Also
What is Shin Nippon Biomedical Laboratories Ltd's Cash from Operating Activities?
Cash from Operating Activities
1.9B
JPY
Based on the financial report for Dec 31, 2023, Shin Nippon Biomedical Laboratories Ltd's Cash from Operating Activities amounts to 1.9B JPY.
What is Shin Nippon Biomedical Laboratories Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
-8%
Over the last year, the Cash from Operating Activities growth was -73%. The average annual Cash from Operating Activities growth rates for Shin Nippon Biomedical Laboratories Ltd have been -11% over the past three years , -8% over the past five years .